Malaria

P. falciparum Malaria: Developing a Synthetic Subunit Candidate Vaccine

Malaria is one of the most serious infectious diseases of humans, infecting 5–10% of the world’s population, with 300–600 million clinical cases and more than 2 million deaths annually. Moreover, malaria is a major social and economic burden in endemic areas. In recent years, malaria has spread at an alarming rate owing to the increasing resistance of the parasite to drugs, and the resistance of mosquitoes to insecticides. Therefore, new approaches to combat malaria are urgently needed, and a vaccine is predicted to have the greatest impact in addition to being the most cost-effective control measure.

Links

Vaccine Development

One approach is to design a subunit vaccine that incorporates several malaria protein antigens for which there is evidence of protective immunity from epidemiological data or experimental animal challenge models. Development of such subunit vaccines is critically dependent on the availability of an antigen delivery system to drive suitable protein antigen-specific immune responses in humans. Vaccine formulations have to be highly effective, human-compatible and safe. Production of synthetic or recombinant proteins that stably mimic the native structure of the corresponding malaria antigens to induce effective humoral immune responses is a further major challenge.

Our research

We are addressing both problems by developing synthetic peptide structures that induce cross-reactive antibodies against the parent malaria proteins and by coupling them to the surface of immunopotentiating reconstituted influenza virosomes (IRIVs). In addition we are evaluating the use of so fare uncharacterized predicted proteins of Plasmodium falciparum as potential new candidate vaccine antigens.

Bottazzi P, Winkler M.S, Speranza C.I. Flood governance for resilience in cities: the historical policy transformations in Dakar's suburbs. Environ Sci Policy. 2019(in press). DOI: 10.1016/j.envsci.2018.12.013

Carsin A.E et al. Restrictive spirometry pattern is associated with low physical activity levels. A population based international study. Respir Med. 2019;146:116-123. DOI: 10.1016/j.rmed.2018.11.017

Ghosh R.E et al. Fetal growth, stillbirth, infant mortality and other birth outcomes near UK municipal waste incinerators; retrospective population based cohort and case-control study. Environ Int. 2019;122:151-158. DOI: 10.1016/j.envint.2018.10.060

Jeong J, Obradovic J, Rasheed M, McCoy D.C, Fink G, Yousafzai A.K. Maternal and paternal stimulation: mediators of parenting intervention effects on preschoolers' development. J Appl Dev Psychol. 2019;60:105-118. DOI: 10.1016/j.appdev.2018.12.001

Keitel K. Biomarkers to improve rational antibiotic use in low-resource settings. Lancet Glob Health. 2019;7(1):e14-e15. DOI: 10.1016/S2214-109X(18)30497-2

Laager M et al. A metapopulation model of dog rabies transmission in N'Djamena, Chad. J Theor Biol. 2019;462:408-417. DOI: 10.1016/j.jtbi.2018.11.027

Lee T.E, Penny M.A. Identifying key factors of the transmission dynamics of drug-resistant malaria. J Theor Biol. 2019;462:210-220. DOI: 10.1016/j.jtbi.2018.10.050

Mattli R, Wieser S, Probst-Hensch N, Schmidt-Trucksäss A, Schwenkglenks M. Physical inactivity caused economic burden depends on regional cultural differences. Scand J Med Sci Sports. 2019;29(1):95-104. DOI: 10.1111/sms.13311

Mhimbira F et al. Prevalence and clinical significance of respiratory viruses and bacteria detected in tuberculosis patients compared to household contact controls in Tanzania: a cohort study. Clin Microbiol Infect. 2019;25(1):107 e1-107 e7. DOI: 10.1016/j.cmi.2018.03.019

Mitsakou C et al. Environmental public health risks in European metropolitan areaswithin the EURO-HEALTHY project. Sci Total Environ. 2019;658:1630-1639. DOI: 10.1016/j.scitotenv.2018.12.130